Skip to content

Clinical trials

Neuralgia trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuralgia Country / region: South Korea Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20101
20124
20132
20141
20151
20164
20173
20181
20194
20201
20211
20223
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Unknown status10
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GL Pharm Tech Corporation3
Seoul National University3
Seoul National University Hospital3
The Catholic University of Korea3
Catholic University of Korea Saint Paul's Hospital2
Hangang Sacred Heart Hospital2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Eli Lilly and Company1
GlaxoSmithKline1
Hanyang University Seoul Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuralgia31
Diabetic Neuropathies6
Neuralgia, Postherpetic5
Spinal Cord Injuries4
Burns2
Osteoarthritis2
Pain2
Chronic Pain1
Complex Regional Pain Syndromes1
Diabetes Mellitus1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.